Otolaryngology Doctors in Greenbelt, MD Accepting Medicare

5 Otolaryngology doctors found. Showing 1 - 5

Kanaiyalal Patel, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7231 Hanover Pkwy, Suite B, Greenbelt, MD 20770 Phone: 301-441-3122    Fax: 301-441-3124

Perry William Alexion, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 7500 Hanover Parkway, Ste 207, Greenbelt, MD 20770 Phone: 301-441-8711    Fax: 301-441-4859

Atur Patel, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 7235 Hanover Pkwy Ste B, Greenbelt, MD 20770 Phone: 301-441-3122

Dr. Rodrigo Martinez, M.D. Otolaryngology - Facial Plastic Surgery Medicare: Medicare Enrolled Practice Location: 7231 Hanover Pkwy, Suite B, Greenbelt, MD 20770 Phone: 301-441-3124    Fax: 301-441-3124

Michael Joseph Damiano, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7500 Hanover Parkway, Suite 207, Greenbelt, MD 20770 Phone: 301-441-8711    Fax: 301-441-4859

News Archive

Viewpoints: Drug shortages = rationing; Changing forces in health marketplace; Birth control mandate

A widespread shortage of prescription drugs is hampering the treatment of patients who have cancer, severe infections and other serious illnesses. While some Republican politicians have railed against the imaginary threat of rationing under health care reform, Congress has done nothing to alleviate the all-too-real rationing of lifesaving drugs caused by this crisis.

Weight training may help the elderly retain muscle

Have you ever noticed that people have thinner arms and legs as they get older? As we age it becomes harder to keep our muscles healthy. They get smaller, which decreases strength and increases the likelihood of falls and fractures. New research is showing how this happens — and what to do about it.

Researchers identify novel gene critical to development of lung and pancreatic cancer

Researchers at the Center for Applied Medical Research of the University of Navarra have identified a critical gene, FOSL1, in the development of lung and pancreatic cancer.

New data suggest PaQ device can reduce known barriers to insulin therapy among people with type 2 diabetes

CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that comprehensive data from a study of the company's PaQ Insulin Delivery Device will be presented today and tomorrow at the American Diabetes Association 73rd Scientific Sessions in Chicago, IL. The data suggest that PaQ can reduce known barriers to insulin therapy among people with type 2 diabetes, potentially improving their glycemic control.

Read more Medical News

› Verified 3 days ago